Filgotinib Reduces Flare Risk in Uveitis in Phase 2 Study
Phase 2 data on filgotinib show a reduction in risk of flare in patients with uveitis and good tolerance in one of the first studies of a JAK inhibitor in uveitis.
Source: medscape.com
Page 9 - Visual Acuity News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Visual Acuity. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Visual Acuity Today - Breaking & Trending Today
Visual Perception Test Distinguishes AD From Lewy Body Dementia
The easily administered Fragmented Letters Test can accurately identify whether mild to moderate dementia is associated with Lewy body disease or Alzheimer's disease, new research suggests.
Source: medscape.com
IOCT for IMM surgery
Evaluating the feasibility and practicability of IOCT in the surgery of idiopathic macular epiretinal membrane (IMM) without internal limiting membrane staining
Source: dovepress.com
Pixium Vision announces the implementation of a financing
Pixium Vision announces the implementation of a financing of a maximum nominal amount of €30 million, and the drawdown of a first tranche of €5.5 million. ...
Source: globenewswire.com
Bevacizumab First Matches Aflibercept for Diabetic Macular Edema
Results from a randomized trial showed that step therapy for diabetic macular edema with lower-priced bevacizumab followed by pricier aflibercept, when needed, works as well as aflibercept monotherapy.
Source: medscape.com